201 related articles for article (PubMed ID: 21352854)
1. Triggering of toll-like receptor signaling pathways in T cells contributes to the anti-tumor efficacy of T cell responses.
Salem ML
Immunol Lett; 2011 Jun; 137(1-2):9-14. PubMed ID: 21352854
[TBL] [Abstract][Full Text] [Related]
2. Insights into the role of Toll-like receptors in modulation of T cell responses.
Kulkarni R; Behboudi S; Sharif S
Cell Tissue Res; 2011 Jan; 343(1):141-52. PubMed ID: 20680345
[TBL] [Abstract][Full Text] [Related]
3. TLR ligand suppression or enhancement of Treg cells? A double-edged sword in immunity to tumours.
Conroy H; Marshall NA; Mills KH
Oncogene; 2008 Jan; 27(2):168-80. PubMed ID: 18176598
[TBL] [Abstract][Full Text] [Related]
4. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
5. Direct and indirect role of Toll-like receptors in T cell mediated immunity.
Xu D; Liu H; Komai-Koma M
Cell Mol Immunol; 2004 Aug; 1(4):239-46. PubMed ID: 16225766
[TBL] [Abstract][Full Text] [Related]
6. Role of Toll-like receptor-driven innate immunity in thoracic organ transplantation.
Goldstein DR; Palmer SM
J Heart Lung Transplant; 2005 Nov; 24(11):1721-9. PubMed ID: 16297771
[TBL] [Abstract][Full Text] [Related]
7. [Innate immunity: structure and function of TLRs].
Delneste Y; Beauvillain C; Jeannin P
Med Sci (Paris); 2007 Jan; 23(1):67-73. PubMed ID: 17212934
[TBL] [Abstract][Full Text] [Related]
8. T cell-dependent and -independent IgA responses: role of TLR signalling.
Bessa J; Bachmann MF
Immunol Invest; 2010; 39(4-5):407-28. PubMed ID: 20450285
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptors and genital tract infection.
Sonnex C
Int J STD AIDS; 2010 Mar; 21(3):153-7. PubMed ID: 20215617
[TBL] [Abstract][Full Text] [Related]
10. Dendritic cells from bench to bedside and back.
Adema GJ
Immunol Lett; 2009 Feb; 122(2):128-30. PubMed ID: 19121337
[TBL] [Abstract][Full Text] [Related]
11. TLR based therapeutics.
Dunne A; Marshall NA; Mills KH
Curr Opin Pharmacol; 2011 Aug; 11(4):404-11. PubMed ID: 21501972
[TBL] [Abstract][Full Text] [Related]
12. Ampligen: a potential toll-like 3 receptor adjuvant for immunotherapy of cancer.
Jasani B; Navabi H; Adams M
Vaccine; 2009 May; 27(25-26):3401-4. PubMed ID: 19200817
[TBL] [Abstract][Full Text] [Related]
13. Differential immune effects mediated by Toll-like receptors stimulation in precursor B-cell acute lymphoblastic leukaemia.
Corthals SL; Wynne K; She K; Shimizu H; Curman D; Garbutt K; Reid GS
Br J Haematol; 2006 Feb; 132(4):452-8. PubMed ID: 16412017
[TBL] [Abstract][Full Text] [Related]
14. Control of B-cell responses by Toll-like receptors.
Pasare C; Medzhitov R
Nature; 2005 Nov; 438(7066):364-8. PubMed ID: 16292312
[TBL] [Abstract][Full Text] [Related]
15. Engagement of TLR signaling as adjuvant: towards smarter vaccine and beyond.
Lahiri A; Das P; Chakravortty D
Vaccine; 2008 Dec; 26(52):6777-83. PubMed ID: 18835576
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptor (TLR) 2-9 agonists-induced cytokines and chemokines: I. Comparison with T cell receptor-induced responses.
Ghosh TK; Mickelson DJ; Fink J; Solberg JC; Inglefield JR; Hook D; Gupta SK; Gibson S; Alkan SS
Cell Immunol; 2006 Sep; 243(1):48-57. PubMed ID: 17250816
[TBL] [Abstract][Full Text] [Related]
17. BDCA-2 signaling inhibits TLR-9-agonist-induced plasmacytoid dendritic cell activation and antigen presentation.
Jähn PS; Zänker KS; Schmitz J; Dzionek A
Cell Immunol; 2010; 265(1):15-22. PubMed ID: 20673884
[TBL] [Abstract][Full Text] [Related]
18. A balance between tissue-destructive and tissue-protective immunities: a role of toll-like receptors in regulation of adaptive immunity.
Seledtsov VI; Seledtsova GV
Immunobiology; 2012 Apr; 217(4):430-5. PubMed ID: 22099351
[TBL] [Abstract][Full Text] [Related]
19. Efficient stimulation of T cell responses by human IFN-alpha-induced dendritic cells does not require Toll-like receptor triggering.
Bracci L; Schumacher R; Provenzano M; Adamina M; Rosenthal R; Groeper C; Zajac P; Iezzi G; Proietti E; Belardelli F; Spagnoli GC
J Immunother; 2008 Jun; 31(5):466-74. PubMed ID: 18463538
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor regulation of effector T lymphocyte function.
Reynolds JM; Dong C
Trends Immunol; 2013 Oct; 34(10):511-9. PubMed ID: 23886621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
